Crohn's Disease Clinical Trials in Philadelphia

Showing 61-80 of 131 trials

Treating IBD With Inulin

NCT03653481

The purpose of this study is to see how the prebiotic inulin changes the gut bacteria (microbiome) of children and young adults with IBD and determine if this dietary intervention can help reduce disease activity.

Inflammatory Bowel Diseases

Children's Hospital of Philadelphia51 participantsStarted Oct 2018

Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

NCT00790543

The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.

Crohn's Disease

Emory University1,813 participantsStarted Nov 2008

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +25 more locations

Treating IBD With Inulin

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

Crohn's Disease Trials in Other Cities

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

B0151005 Open-Label Extension Study

Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

A Study To Monitor Long-Term Treatment With PF-00547659

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Manipulating the Microbiome in IBD by Antibiotics and FMT

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Other Conditions in Philadelphia